GHRP-2 given to healthy men by subcutaneous infusion raised growth hormone more than 13 times compared with saline. Every one of them then ate more, on average 35.9 percent. In Japan GHRP-2 is a recommended test that detects growth hormone deficiency in an hour or less. A study in children also showed the limit of its effect: 48 weeks of nasal spray did not speed up growth. Below we collect six human studies and compare the two GHRP-2 versions in the shop, both for 25 EUR.
What is GHRP-2?
GHRP-2, also called pralmorelin in the literature, is a short growth hormone releasing peptide. It was developed by Cyril Bowers' team at Tulane University. It acts through the ghrelin receptor, the receptor of the hunger hormone made in the stomach, and stimulates the pituitary to release its own growth hormone.
GHRP-6, ipamorelin and hexarelin use the same receptor. The differences between them are mapped in GHRP-2, GHRP-6 and ipamorelin compared, and how the whole group works is explained in growth hormone peptides: GHRH, GHRP and ghrelin.
How much growth hormone does GHRP-2 release in humans?
In a 2005 study, seven lean healthy men received GHRP-2 or saline by subcutaneous infusion lasting 270 minutes. The total amount of growth hormone in the blood was 5550 units with GHRP-2 against 412 with saline, more than 13 times as much.
A strong response was confirmed by a 2013 study from Hiroshima in 71 adults before pituitary surgery. The median growth hormone peak after GHRP-2 was 28.88 µg/l, and after the classic insulin test 9.38 µg/l. GHRP-2 thus gave a peak three times higher than the insulin test, until then considered the most reliable.
How does GHRP-2 detect growth hormone deficiency?
A pituitary that does not make enough growth hormone responds weakly to GHRP-2. The difference is so clear that in Japan GHRP-2 is recommended as an alternative to the insulin test, which cannot be done in some patients.
| Study | Who | Result |
|---|---|---|
| Asakura 2010, Kanagawa | 56 children with growth disorders | growth hormone peak 3.39 µg/l with deficiency against 25.10 µg/l without; the test took an hour or less |
| Kinoshita 2013, Hiroshima | 71 adults with a pituitary tumour | in severe deficiency sensitivity 81.3 percent and specificity 94.5 percent against the insulin test |
The Kanagawa researchers set the cut-off for children at 15 µg/l. The same value was given in a 2004 review of pralmorelin, which described GHRP-2 as a diagnostic agent.
Does GHRP-2 increase appetite?
Yes, in every study that measured it. In the 2005 study men ate 35.9 percent more at a buffet after a GHRP-2 infusion than after saline. The increase applied to each of the seven participants, also per kilogram of body weight, and the make-up of the food eaten did not change.
In Chile ten children with growth hormone deficiency took GHRP-2 by mouth twice a day for 12 months. Seven of them reported a clearly bigger appetite in the first six months. Their body mass index did not rise significantly, so the effect on appetite turned out to be temporary.
When you are building mass and cannot eat enough calories, the strong hunger after GHRP-2 is an advantage. For fat loss ipamorelin works better, because it stimulates appetite less, as described in why ipamorelin is called a selective GHRP.
What does longer use of GHRP-2 give?
The longest placebo-controlled study was done in Japan. 126 short children with growth hormone deficiency received a nasal spray with GHRP-2 at two doses, or placebo, twice a day for 48 weeks. Growth rate did not differ between the three groups, and IGF-1 levels did not change. The authors concluded that the short hormone burst after the spray was too small to have a biological effect.
A continuous infusion looked different. In Leuven 33 men with prolonged critical illness in intensive care received GHRP-2, its combinations with other hormones, or placebo for five days. GHRP-2 alone restored their growth hormone secretion and normalised IGF-1. Better protein metabolism, however, came only from the combinations with TRH and GnRH, not from GHRP-2 alone.
The practical conclusion from both studies is that what counts is how long growth hormone stays in the blood, not a single peak. How soon growth hormone itself shows results is covered in growth hormone in adults: results timeline.
What to watch out for with GHRP-2?
Besides growth hormone, GHRP-2 also raises cortisol, ACTH and prolactin in humans, as described in the GHRP comparison. It is not a registered medicine in the European Union, and the shop sells it as research material. In sport it is banned all year round, in class S2 of the WADA 2026 list.
Where to buy GHRP-2 and how much does it cost?
| Version | Pack | Per 1 U-100 unit | Price |
|---|---|---|---|
| GHRP-2 10 mg Bio-Peptide | vial and 2 ampoules of 1 ml | 100 or 50 mcg | 25 EUR |
| GHRP-2 10 mg Nouveaux Ltd. | two-chamber cartridge with 1 ml of solvent | 100 mcg | 25 EUR |
The Bio-Peptide vial has two ampoules, so you can dissolve it in 2 ml and measure more finely. The Nouveaux Ltd. cartridge is prepared without transferring liquid. If you want to combine GHRP-2 with a peptide from the GHRH group, the shop has the GHRP-2 with CJC-1295 cartridge from Nouveaux Ltd. for 35 EUR. All versions are on the GHRP-2 page. Its sister molecule is covered in GHRP-6: results in humans.
GHRP-2 10 mg by Bio-Peptide
25 EUR82,00 złAdd to cartIn stock
Ships within 24 h
GHRP-2 10 mg by Nouveaux Ltd.
25 EUR99,00 złAdd to cartIn stock
Ships within 24 h
GHRP-2 & CJC-1295 Combo 10 mg by Nouveaux Ltd.
35 EUR140,00 złAdd to cartIn stock
Ships within 24 h
GHRP-2 10 mg by Genheal
20 EUR78,00 złAdd to cartIn stock
Ships within 24 h
Frequently asked questions
How much growth hormone does GHRP-2 release?
By subcutaneous infusion in healthy men it released more than 13 times as much as saline. In adults before pituitary surgery the peak after GHRP-2 was three times higher than after the insulin test.
Does GHRP-2 increase appetite?
Yes, healthy men ate 35.9 percent more after it, and seven of ten children reported a bigger appetite in the first half year of use.
Does GHRP-2 speed up growth in children?
In a placebo-controlled study in 126 children, a nasal spray for 48 weeks did not speed up growth or change IGF-1.
What is GHRP-2 used for in medicine?
In Japan it is used for a test that detects growth hormone deficiency in children and adults. The test takes an hour or less.
How much does GHRP-2 cost in the shop?
The Bio-Peptide 10 mg vial with two ampoules and the Nouveaux Ltd. 10 mg cartridge cost 25 EUR each.
Sources
- Laferrère B, Abraham C, Russell CD, Bowers CY. Growth hormone releasing peptide-2 (GHRP-2), like ghrelin, increases food intake in healthy men. Journal of Clinical Endocrinology and Metabolism, 2005, 90(2): 611-614. https://pubmed.ncbi.nlm.nih.gov/15699539/
- Kinoshita Y, Tominaga A, Usui S et al. The arginine and GHRP-2 tests as alternatives to the insulin tolerance test for the diagnosis of adult GH deficiency in Japanese patients: a comparison. Endocrine Journal, 2013, 60(1): 97-105. https://pubmed.ncbi.nlm.nih.gov/23079545/
- Asakura Y, Toyota Y, Muroya K, Adachi M. Growth hormone response to GH-releasing peptide-2 in children. Journal of Pediatric Endocrinology and Metabolism, 2010, 23(5): 473-480. https://pubmed.ncbi.nlm.nih.gov/20662346/
- Pralmorelin: GHRP 2, GPA 748, growth hormone-releasing peptide 2, KP-102 D, KP-102 LN. Drugs in R&D, 2004, 5(4): 236-239. https://pubmed.ncbi.nlm.nih.gov/15230633/
- Mericq V, Cassorla F, Bowers CY et al. Changes in appetite and body weight in response to long-term oral administration of the ghrelin agonist GHRP-2 in growth hormone deficient children. Journal of Pediatric Endocrinology and Metabolism, 2003, 16(7): 981-985. https://pubmed.ncbi.nlm.nih.gov/14513874/
- Tanaka T, Hasegawa Y, Yokoya S, Nishi Y. Increased Secretion of Endogenous GH after Treatment with an Intranasal GH-releasing Peptide-2 Spray Does Not Promote Growth in Short Children with GH Deficiency. Clinical Pediatric Endocrinology, 2014, 23(4): 107-114. https://pubmed.ncbi.nlm.nih.gov/25374440/
- Van den Berghe G, Baxter RC, Weekers F et al. The combined administration of GH-releasing peptide-2 (GHRP-2), TRH and GnRH to men with prolonged critical illness evokes superior endocrine and metabolic effects compared to treatment with GHRP-2 alone. Clinical Endocrinology, 2002, 56(5): 655-669. https://pubmed.ncbi.nlm.nih.gov/12030918/




